Table of Contents

2019-2024 Global Drugs for Malaria Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Drugs for Malaria Consumption 2014-2024
  • 2.1.2 Drugs for Malaria Consumption CAGR by Region
• 2.2 Drugs for Malaria Segment by Type
  • 2.2.1 Aryl Aminoalcohol Compounds
  • 2.2.2 Antifolate Compounds
  • 2.2.3 Artemisinin Compounds
• 2.3 Drugs for Malaria Consumption by Type
  • 2.3.1 Global Drugs for Malaria Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Drugs for Malaria Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Drugs for Malaria Sale Price by Type (2014-2019)
• 2.4 Drugs for Malaria Segment by Application
  • 2.4.1 Prevention
  • 2.4.2 Treatment
  • 2.4.3 Other
• 2.5 Drugs for Malaria Consumption by Application
  • 2.5.1 Global Drugs for Malaria Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Drugs for Malaria Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Drugs for Malaria Sale Price by Application (2014-2019)

3 Global Drugs for Malaria by Players

• 3.1 Global Drugs for Malaria Sales Market Share by Players
  • 3.1.1 Global Drugs for Malaria Sales by Players (2017-2019)
  • 3.1.2 Global Drugs for Malaria Sales Market Share by Players (2017-2019)
• 3.2 Global Drugs for Malaria Revenue Market Share by Players
  • 3.2.1 Global Drugs for Malaria Revenue by Players (2017-2019)
  • 3.2.2 Global Drugs for Malaria Revenue Market Share by Players (2017-2019)
• 3.3 Global Drugs for Malaria Sale Price by Players
• 3.4 Global Drugs for Malaria Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Drugs for Malaria Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Drugs for Malaria Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Drugs for Malaria by Regions

• 4.1 Drugs for Malaria by Regions
  • 4.1.1 Global Drugs for Malaria Consumption by Regions
  • 4.1.2 Global Drugs for Malaria Value by Regions
• 4.2 Americas Drugs for Malaria Consumption Growth
• 4.3 APAC Drugs for Malaria Consumption Growth
• 4.4 Europe Drugs for Malaria Consumption Growth
• 4.5 Middle East & Africa Drugs for Malaria Consumption Growth

5 Americas

• 5.1 Americas Drugs for Malaria Consumption by Countries
  • 5.1.1 Americas Drugs for Malaria Consumption by Countries (2014-2019)
  • 5.1.2 Americas Drugs for Malaria Value by Countries (2014-2019)
• 5.2 Americas Drugs for Malaria Consumption by Type
• 5.3 Americas Drugs for Malaria Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Drugs for Malaria Consumption by Countries
  • 6.1.1 APAC Drugs for Malaria Consumption by Countries (2014-2019)
  • 6.1.2 APAC Drugs for Malaria Value by Countries (2014-2019)
• 6.2 APAC Drugs for Malaria Consumption by Type
• 6.3 APAC Drugs for Malaria Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Drugs for Malaria by Countries
  • 7.1.1 Europe Drugs for Malaria Consumption by Countries (2014-2019)
  • 7.1.2 Europe Drugs for Malaria Value by Countries (2014-2019)
• 7.2 Europe Drugs for Malaria Consumption by Type
• 7.3 Europe Drugs for Malaria Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Drugs for Malaria by Countries
  • 8.1.1 Middle East & Africa Drugs for Malaria Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Drugs for Malaria Value by Countries (2014-2019)
• 8.2 Middle East & Africa Drugs for Malaria Consumption by Type
• 8.3 Middle East & Africa Drugs for Malaria Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Drugs for Malaria Distributors
• 10.3 Drugs for Malaria Customer

11 Global Drugs for Malaria Market Forecast

• 11.1 Global Drugs for Malaria Consumption Forecast (2019-2024)
• 11.2 Global Drugs for Malaria Forecast by Regions
  • 11.2.1 Global Drugs for Malaria Forecast by Regions (2019-2024)
  • 11.2.2 Global Drugs for Malaria Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Drugs for Malaria Forecast by Type
• 11.8 Global Drugs for Malaria Forecast by Application

12 Key Players Analysis

• 12.1 Cipla
  • 12.1.1 Company Details
  • 12.1.2 Drugs for Malaria Product Offered
  • 12.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Cipla News
• 12.2 Guilin Pharmaceutical
  • 12.2.1 Company Details
  • 12.2.2 Drugs for Malaria Product Offered
  • 12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Guilin Pharmaceutical News
• 12.3 IPCA Laboratories
  • 12.3.1 Company Details
  • 12.3.2 Drugs for Malaria Product Offered
  • 12.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 IPCA Laboratories News
• 12.4 GlaxoSmithKline
  • 12.4.1 Company Details
  • 12.4.2 Drugs for Malaria Product Offered
  • 12.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 GlaxoSmithKline News
• 12.5 Mylan Labs
  • 12.5.1 Company Details
  • 12.5.2 Drugs for Malaria Product Offered
  • 12.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Mylan Labs News
• 12.6 Roche
  • 12.6.1 Company Details
  • 12.6.2 Drugs for Malaria Product Offered
  • 12.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Roche News
• 12.7 Novartis
  • 12.7.1 Company Details
  • 12.7.2 Drugs for Malaria Product Offered
  • 12.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Novartis News
• 12.8 Sanofi Aventis
  • 12.8.1 Company Details
  • 12.8.2 Drugs for Malaria Product Offered
  • 12.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Sanofi Aventis News
• 12.9 Ajanta Pharma
  • 12.9.1 Company Details
  • 12.9.2 Drugs for Malaria Product Offered
  • 12.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Ajanta Pharma News

13 Research Findings and Conclusion

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.

According to this study, over the next five years the Drugs for Malaria market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Drugs for Malaria business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Malaria market by product type, application, key manufacturers and key regions and countries.

This study considers the Drugs for Malaria value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Prevention
Treatment
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Drugs for Malaria consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Drugs for Malaria market by identifying its various subsegments.
Focuses on the key global Drugs for Malaria manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for Malaria with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Drugs for Malaria submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.